Skip to Main Content

Paper Details

Pain Control after Intravitreal Injection Using Topical Nepafenac 0.3% or Pressure Patching: A Randomized, Placebo-Controlled Trial.
Ophthalmol Retina
7
2019
Nepafenac, PARTICIPANTS, Participants, aflibercept, bevacizumab, nepafenac, patient, patients, triamcinolone acetonide
Author NameAffiliation
Alexander BarashNew York Eye & Ear Infirmary of Mount Sinai
Richard B RosenNew York Eye & Ear Infirmary of Mount Sinai
Ronald C GentileNew York Eye & Ear Infirmary of Mount Sinai, NYU Winthrop Hospital
  • 1 - 3

Datasets

Release 1.2